Literature DB >> 18582183

Psychotropic medication use in children and adolescents: a study from France.

Christine Sevilla-Dedieu1, Viviane Kovess-Masféty.   

Abstract

OBJECTIVE: In Europe, little information exists on the pediatric use of psychotropic medication. This study aimed to describe the extent and patterns of psychotropic medication use in children and adolescents enrolled in a large health plan (MGEN) in France, and its evolution in recent years.
METHODS: MGEN affiliates aged 0 to 17 years were randomly selected at the end of three consecutive years, 2003 (n = 6534), 2004 (n = 6625), and 2005 (n = 6704). Reimbursement claims were organized into three 1-year cross-sectional data sets. Results are detailed for the year 2003 only.
RESULTS: In 2003, psychotropic medication, principally anxiolytics and hypnotics, concerned 3.3% of children and adolescents, of whom 35.0% used only herbal drugs. General practitioners were found to be behind most of these prescriptions (63.5%) and, worryingly, 15.1% were drugs restricted to adult use. Nevertheless, most psychotropic medication users (71.0%) had only one prescription. In general, psychotropic medication users received a relatively good medical follow-up. Similar results were found for the years 2004 and 2005.
CONCLUSION: No increasing trend in prevalence was found. However, a subject for concern is the proportion of psychotropic drugs with no market authorization for pediatric use that were prescribed to young patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18582183     DOI: 10.1089/cap.2007.0091

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  5 in total

1.  Medication use in adolescents treated in a French psychiatric setting for acute manic or mixed episode.

Authors:  Angèle Consoli; Julie Brunelle; Nicolas Bodeau; Didier Périsse; Emmanuelle Deniau; Jean-Marc Guilé; David Cohen
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2009-08

2.  National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.

Authors:  Jonathan S Comer; Mark Olfson; Ramin Mojtabai
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-09-01       Impact factor: 8.829

3.  Use of SSRIs among Danish children: a nationwide study.

Authors:  Anton Pottegård; Helga Zoëga; Jesper Hallas; Per Damkier
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-02-04       Impact factor: 4.785

4.  A Framework for Developing a Curriculum Regarding Autism Spectrum Disorders for Primary Care Providers.

Authors:  Pankaj Garg; David Lillystone; David Dossetor; Helen Wilkinson; Carolyn Kefford; John Eastwood; Siaw Teng Liaw
Journal:  J Clin Diagn Res       Date:  2015-10-01

5.  Psychotropic medication in the French child and adolescent population: prevalence estimation from health insurance data and national self-report survey data.

Authors:  Eric Acquaviva; Stéphane Legleye; Guy R Auleley; Jean Deligne; Didier Carel; Bruno Falissard B
Journal:  BMC Psychiatry       Date:  2009-11-17       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.